Updates on Management of Gastric Cancer
- PMID: 31236716
- DOI: 10.1007/s11912-019-0820-4
Updates on Management of Gastric Cancer
Abstract
Purpose of review: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection.
Recent findings: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.
Keywords: CYTO-CHIP; FLOT; Gastric adenocarcinoma; Gastric cancer; HIPEC; Siewert type III.
Similar articles
-
Current treatment and recent progress in gastric cancer.CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16. CA Cancer J Clin. 2021. PMID: 33592120 Free PMC article. Review.
-
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2. Epub 2016 Feb 5. Cancer Chemother Pharmacol. 2016. PMID: 26846507 Clinical Trial.
-
Current Management of Locally Advanced Junction Esophagogastric Adenocarcinoma.Chirurgia (Bucur). 2018 Jan-Feb;113(1):38-45. doi: 10.21614/chirurgia.113.1.38. Chirurgia (Bucur). 2018. PMID: 29509530 Review.
-
Modern oncological approaches to gastric adenocarcinoma.Gastroenterol Clin North Am. 2013 Jun;42(2):359-69. doi: 10.1016/j.gtc.2013.01.011. Epub 2013 Mar 1. Gastroenterol Clin North Am. 2013. PMID: 23639645 Review.
-
Optimizing Therapies in the Perioperative Management of Gastric Cancer.Curr Treat Options Oncol. 2019 May 29;20(7):57. doi: 10.1007/s11864-019-0654-1. Curr Treat Options Oncol. 2019. PMID: 31144054 Review.
Cited by
-
Diagnostic Potential of miR-143-5p, miR-143-3p, miR-551b-5p, and miR-574-3p in Chemoresistance of Locally Advanced Gastric Cancer: A Preliminary Study.Int J Mol Sci. 2024 Jul 24;25(15):8057. doi: 10.3390/ijms25158057. Int J Mol Sci. 2024. PMID: 39125625 Free PMC article.
-
Pyroptosis impacts the prognosis and treatment response in gastric cancer via immune system modulation.Am J Cancer Res. 2022 Apr 15;12(4):1511-1534. eCollection 2022. Am J Cancer Res. 2022. PMID: 35530274 Free PMC article.
-
Cancer-associated fibroblast-released extracellular vesicles carrying miR-199a-5p induces the progression of gastric cancer through regulation of FKBP5-mediated AKT1/mTORC1 signaling pathway.Cell Cycle. 2022 Dec;21(24):2590-2601. doi: 10.1080/15384101.2022.2105092. Epub 2022 Aug 25. Cell Cycle. 2022. PMID: 36005478 Free PMC article.
-
Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells.Cell Biol Int. 2022 May;46(5):747-754. doi: 10.1002/cbin.11766. Epub 2022 Feb 16. Cell Biol Int. 2022. PMID: 35066967 Free PMC article.
-
Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy.Pharmaceutics. 2022 Jul 29;14(8):1576. doi: 10.3390/pharmaceutics14081576. Pharmaceutics. 2022. PMID: 36015202 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials